Nymox Pharmaceutical Corporation Stock News

Nymox Pharmaceutical Corporation (NYMX) is pleased to announce that a new peer review report was published today in the World Journal of Urology, documenting the successful long-term clinical trial re

Gainers Schrodinger, Inc. (NASDAQ: SDGR) shares jumped 68.5% to close at $28.64 on Thursday after the company priced its IPO at $17 per share. Yield10 Bioscience, Inc. (NASDAQ:...

Nymox Pharmaceutical Corporation (NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC to the position of Nymox Vice President of Quality and Regulatory Affairs. Dr Thoms

The CEO of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is Paul Averback. This report will, first, examine the CEO...

Friday's morning session saw 152 companies set new 52-week highs. Interesting Highlights: Amazon.com (NASDAQ: AMZN) was the largest company by market cap to set a...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (

During Thursday's morning trading, 142 companies set new 52-week highs. Points of Interest: BlackRock MuniHoldings (NYSE: MUC) was the largest firm on a market cap...

HASBROUCK HEIGHTS, N.J., Jan. 28, 2020 -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide a current January 2020 update on several important corporate.

The following is a roundup of top developments in the biotech space over the last 24 hours.  Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 6.) Agile Therapeutics Inc (NASDAQ: AGRX

HASBROUCK HEIGHTS, N.J., Jan. 06, 2020 -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to report a new peer review research report has been published on.